These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33095745)

  • 1. Design of dual hormone blood glucose therapy and comparison with single hormone using MPC algorithm.
    Dias CC; Kamath S; Vidyasagar S
    IET Syst Biol; 2020 Oct; 14(5):241-251. PubMed ID: 33095745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a dual-hormone model predictive control for artificial pancreas with exercise model.
    Resalat N; El Youssef J; Reddy R; Jacobs PG
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2270-2273. PubMed ID: 28324962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.
    Tang F; Wang Y
    J Diabetes Sci Technol; 2017 Nov; 11(6):1112-1123. PubMed ID: 28728434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
    Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.
    Grosman B; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
    J Diabetes Sci Technol; 2010 Jul; 4(4):961-75. PubMed ID: 20663463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.
    Magni L; Forgione M; Toffanin C; Dalla Man C; Kovatchev B; De Nicolao G; Cobelli C
    J Diabetes Sci Technol; 2009 Sep; 3(5):1091-8. PubMed ID: 20144422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial.
    Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Obes Metab; 2017 May; 19(5):713-720. PubMed ID: 28094472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
    Haidar A; Rabasa-Lhoret R; Legault L; Lovblom LE; Rakheja R; Messier V; D'Aoust É; Falappa CM; Justice T; Orszag A; Tschirhart H; Dallaire M; Ladouceur M; Perkins BA
    J Clin Endocrinol Metab; 2016 Jan; 101(1):214-23. PubMed ID: 26523526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
    Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies.
    Jacobs PG; El Youssef J; Castle J; Bakhtiani P; Branigan D; Breen M; Bauer D; Preiser N; Leonard G; Stonex T; Ward WK
    IEEE Trans Biomed Eng; 2014 Oct; 61(10):2569-81. PubMed ID: 24835122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control Inputs.
    Resalat N; Hilts W; Youssef JE; Tyler N; Castle JR; Jacobs PG
    J Diabetes Sci Technol; 2019 Nov; 13(6):1044-1053. PubMed ID: 31595784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.
    Jacobs PG; El Youssef J; Reddy R; Resalat N; Branigan D; Condon J; Preiser N; Ramsey K; Jones M; Edwards C; Kuehl K; Leitschuh J; Rajhbeharrysingh U; Castle JR
    Diabetes Obes Metab; 2016 Nov; 18(11):1110-1119. PubMed ID: 27333970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
    Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
    Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel Control of an Artificial Pancreas with Coordinated Insulin, Glucagon, and Rescue Carbohydrate Control Actions.
    Moscardó V; Díez JL; Bondia J
    J Diabetes Sci Technol; 2019 Nov; 13(6):1026-1034. PubMed ID: 31631688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon.
    Jacobs PG; El Youssef J; Castle JR; Engle JM; Branigan DL; Johnson P; Massoud R; Kamath A; Ward WK
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():397-400. PubMed ID: 22254332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.